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The processes underlying the development and
maintenance of tertiary lymphoid organs are incom-
pletely understood. Using a Ccr7 knockout/knockin
approach, we show that spontaneous bronchus-
associated lymphoid tissue (BALT) formation can
be caused by CCR7-mediated migration defects
of dendritic cells (DCs) in the lung. Plt/plt mice that
lack the CCR7 ligands CCL19 and CCL21-serine do
not form BALT spontaneously because lung-ex-
pressed CCL21-leucine presumably suffices to
maintain steady-state DC egress. However, plt/plt
mice are highly susceptible tomodified vaccinia virus
infection, showing enhanced recruitment of immune
cells as well as alterations in CCR7-ligand-mediated
lymphocyte egress from the lungs, leading to
dramatically enhanced BALT. Furthermore, we iden-
tify two independent BALT homing routes for blood-
derived lymphocytes. One is HEV mediated and
depends on CCR7 and L-selectin, while the second
route is via the lung parenchyma and is independent
of these molecules. Together, these data provide in-
sights into CCR7/CCR7-ligand-orchestrated aspects
in BALT formation.
INTRODUCTION
Tertiary lymphoid organs (TLOs) are highly organized lymphoid
structures, develop at sites of infection or chronic immune
stimulation, and have been shown to play crucial roles in the
generation of local immune responses (Halle et al., 2009;
Moyron-Quiroz et al., 2004). Typically, these structures are
named according to the anatomical site of their occurrence,
such as the bronchus-associated lymphoid tissue (BALT) in the
lung. BALT is located adjacent to a bronchus and next to a vein
and artery. BALT is organized similar to secondary lymphoid tis-
sue consisting of B cell follicles, in which germinal centers can
develop, and T cell areas harboring antigen-presenting cells as
well as high endothelial venules (HEVs). HEVs are also found inThis is an open access article under the CC BY-Nlymph nodes (LNs) and are the sites that allow homing of lympho-
cytes from the blood (Fleige et al., 2014; Sminia et al., 1989; Xu
et al., 2003). Importantly, the majority of the interstitial lympho-
cytic infiltrations observed in pulmonary infection does not fulfil
the locational criteria and are thus not considered as BALT.
In the lungs of naive mice, BALT is not detectable but it forms
spontaneously in mice lacking the chemokine receptor CCR7
(Kocks et al., 2007). In that study, our group could demonstrate
that a defect in homing of regulatory T cells rather than impaired
B cell egress from the lung leads to the BALT formation.
Apart from the spontaneous development in Ccr7-deficient
mice, BALT can also be induced by intranasal (i.n.) administra-
tion of viruses including modified vaccinia virus Ankara (MVA),
murine herpes virus-68 (MHV-68), and influenza virus (Halle
et al., 2009; Kocks et al., 2009; Moyron-Quiroz et al., 2004).
Furthermore, repetitive inhalations of heat-killed bacteria (Fleige
et al., 2014; Toyoshima et al., 2000) or of lipopolysaccharide
(LPS) in newborn mice allow induction of BALT (Rangel-Moreno
et al., 2011). In a previous study, we have identified two major
signaling pathways of the chemokine/chemokine receptor
network, CXCL13/CXCR5 and CXCL12/CXCR4, as key factors
of the induction and maturation of BALT (Fleige et al., 2014).
However, the functional relevance of these and other homeostat-
ic chemokines for homing of immune cells into already estab-
lished BALT remained unclear. Whereas it is widely accepted
that homing of naive T cells to lymph nodes via HEVs is
controlled by integrins, selectins, and chemokine receptors (Fo¨r-
ster et al., 2008), little is known how lymphocytes home to TLO.
Xu et al. (2003) have analyzed adhesion molecules expressed on
HEVs present in spontaneous BALT of autoimmune-prone NOD
mice and found that lymphocyte homing is mediated by
L-selectin/PNAd, a4b1 integrin/VCAM1, and the LFA-1 adhesion
pathway whereas a4b7 and MAdCAM are not involved. Similar
roles for L-selectin and a4 integrins have been suggested for hu-
man BALT associated with lung carcinoma (Kawamata et al.,
2009). Some studies show the relevance of chemokine recep-
tors, including CCR7, for trafficking of lymphocytes toward and
within the lung (Bromley et al., 2005; Lo et al., 2003). However,
the role of chemokine receptors and their ligands in lymphocyte
homing to BALT have been addressed very rarely. Analyzing tu-
mor-induced BALT in lung cancer patients revealed the expres-
sion of a set of chemokines (CCL17, CCL19, CCL21, CCL22,Cell Reports 23, 783–795, April 17, 2018 ª 2018 783
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
CXCL13, and interleukin [IL]-16) and their respective receptors
(CCR7, CCR4, and CXCR5) on BALT-infiltrating T cells (de Chai-
semartin et al., 2011). Furthermore, pulmonary expression of
CCR7 and CXCR5 ligands in induced BALT indicating their role
in recruitment of T and B cells to BALT (Fleige et al., 2014; Ran-
gel-Moreno et al., 2007). Even though it is presumed that HEVs,
decorated with chemokines and integrin-ligands represent the
potential entry route for naive lymphocytes to BALT in mice,
this has not been experimentally addressed so far.
In this study, we present data showing the importance of
CCR7-mediated immune cell trafficking for respiratory immuno-
logical homeostasis. Disconnection of the CCR7-signaling
cascade on dendritic cells (DCs) leads to the spontaneous forma-
tion of BALT. Apparently, one remaining isoform of the CCR7
ligand, CCL21-leucine, expressed on pulmonary lymphatic
vessels in plt/pltmice is sufficient to prevent spontaneous BALT
formation in those mice. However, upon MVA stimulation, we
observed increased frequencies of early lymphoid infiltrates and
massive formation of BALT at d12 in plt/pltmice indicating, albeit
indirectly, a crucial role for CCL21-serine in lymphocyte egress
from the lung. Furthermore, CCR7 and its ligands are also
involved in HEV-mediated homing of blood-derived lymphocytes
toBALT, highlighting the essential impact of theCCR7-CCL19/21
axis in different aspects of BALT biology.
RESULTS
Two Routes for Lymphocyte Homing to BALT
We have shown before that naive CD4+ and CD8+ T cells accu-
mulate in MVA-induced BALT following adoptive intravenous
(i.v.) transfer (Halle et al., 2009) but their precise route of BALT
entry had not been studied thus far. We hypothesized that
HEVs in BALT might represent a prominent homing route for
naive lymphocytes. To this end, BALT was induced in wild-
type (WT) mice by a single intranasal dose of MVA. 12 days later,
these mice received fluorescently labeled naive lymphocytes
from C57BL/6 donors by i.v. injection. Immunohistological anal-
ysis of lung frozen sections identified HEVs in MVA-induced
BALT and also identified that adoptively transferred lymphocytes
are about to enter BALT via HEVs 30 min after transfer (Fig-
ure 1A). To further address whether HEVs represent an exclusive
homing route for lymphocytes entering BALT from the circula-
tion, we inhibited homing via HEVs by applying an anti-L-selectin
antibody to the BALT-bearing mice. Subsequently, fluorescently
labeled lymphocytes were transferred i.v., and cells that homed
into BALT were analyzed after defined time intervals. We
observed that anti-L-selectin treatment almost completely
blocked lymphocyte homing to BALT within the first 30 min (Fig-
ures 1B, left, and 1C) but showed no effect when analyzing cell
positioning 4 hr after transfer (Figures 1B, right, and 1C) although
homing to LN was still completely blocked at that time (Figures
S1A–S1D). Many adoptively transferred cells were already found
in the lung parenchyma near the BALT 30 min after transfer (Fig-
ure S1E), suggesting that interstitial lymphocytes can effectively
enter BALT independent of L-selectin. Importantly, similar re-
sults were observed in MVA-induced BALT of plt/plt mice as
well as spontaneous BALT of Ccr7/ mice (Figures 1D and
1E). Together, these findings identify HEVs as a fast homing784 Cell Reports 23, 783–795, April 17, 2018route of blood lymphocytes to BALT and also indicate that lym-
phocytes of the lung parenchyma have access to BALT,
although our experimental set up was not suited to completely
clarify the mechanism of HEV-independent homing to BALT.
We next testedwhether the chemokine receptor CCR7, recog-
nized as an important homing receptor of T cells and CXCR5,
known to guide B cells to B cell follicles, contributes to BALT
homing. Competitive homing of naive WT and Ccr7-deficient
T cells revealed a striking impairment ofCcr7-deficient cells after
30 min but not after 24 hr of transfer (Figures 2A and 2B). These
findings resemble results obtained with anti-L-selectin treatment
of WT recipient mice (Figures 1B–1D). Of note, homing of Cxcr5-
deficient B cells to BALT was not impaired at any time point
investigated (Figures 2C and 2D). Likewise, we were not able
to detect any differences in BALT homing between WT and
Ccr7-defcient DCs, neither 30 min nor 24 hr after intratracheal
transfer (Figures 2E and 2F).
We then asked whether the CCR7-independent homing
mechanisms for lymphocytes to BALT rely on signaling via other
chemokine receptors. To this end, we blocked signaling of all
Gai-coupled receptors by treating cells with pertussis toxin
(ptx) prior to i.v. transfer. 24 hr later, we found 3-fold more
untreated than ptx-treated lymphocytes in the BALT (Figures
2G and 2H) indicating that chemokine receptors also contribute
to the homing of interstitial lymphocytes into BALT. Although
neither Cxcr5- nor Ccr7-deficiency alone had any effect on the
24 hr parenchymal BALT homing of lymphocytes (Figures 2B
and 2D) Cxcr5/Ccr7/ lymphocytes were strongly impaired
in homing into BALT with B cells being more affected than
T cells (Figures 2I and 2J). These findings demonstrate that
CCR7 and CXCR5 synergize in guiding B cells into BALT.
Egress of Lung DCs Prevents the Development of
Spontaneous BALT
Based on previous results demonstrating that intratracheal (i.t.)-
transferred Ccr7-deficient DCs are impaired in egressing from
the lung parenchyma into lymphatic vessels (Hintzen et al.,
2006) and DCs are essential for development and maintenance
of BALT (GeurtsvanKessel et al., 2009; Halle et al., 2009), we
tested the hypothesis that the spontaneously developing BALT
found in Ccr7-deficient mice (Kocks et al., 2007) is caused by
impaired egress of DCs from the lung parenchyma. To this
end, we took advantage of CCR7 ‘‘knockout/knockin’’ mice
(Wendland et al., 2011). In these mice, murine Ccr7 has been
replaced by human CCR7 flanked by a floxed stop cassette.
Thus, crossing these mice with mice expressing the recombi-
nase Cre under cell-type-specific promotors allows the selective
expression of a CCR7 receptor processing the binding of murine
ligands. We analyzed and quantified spontaneous BALT in
mice that neither express mouse nor human CCR7 (Ccr7–/–
CCR7stop/stopwill be referred asCCR7stop/stop), mice that express
only human CCR7 in CD4+ T cells (Ccr7/CCR7+/+Cd4-cre+ will
be referred as T-CCR7+/+) and mice that express only human
CCR7 in CD11c+ DCs (Ccr7/CCR7+/+Cd11c-cre+ will be
referred as DC-CCR7+/+).
BALT is rarely present in WTmice (Figure 3A) but we identified
a considerable number of BALT in Ccr7-deficient, CCR7stop/stop,
and T-CCR7+/+ mice (Figures 3B–3D, top). Spontaneous BALT in
Figure 1. Naive Lymphocytes in the Blood Home to BALT via HEVs
(A and B) Immunofluorescence microscopy of lungs from 8- to 12-week-old C57BL/6 WT mice 12 days after i.n. administration of MVA. Mice were sacrificed
either 30 min (A and B, left) or 4 hr (B, right) after i.v. transfer of TAMRA-labeled naive WT lymphocytes. Mice were untreated (A), treated i.p. with 250 mg anti-L-
selectin antibody (Mel-14; B, bottom) or 250 mg isotype control (1H4; B, top). Frozen lung sections were stained with the antibodies indicated. Bars, 100 mm.
Dashed lines define area of BALT. Arrowheads point to intravenously transferred lymphocytes, which are about to enter BALT via HEVs.
(C–E) Quantification of BALT-homed lymphocytes after i.v. transfer into anti-L-selectin (Mel-14)- or isotype-treated BALT-bearingWT (C),Ccr7/ (D), or plt/plt (E)
mice. Data are derived from at least two independent experiments with 5–8 mice and are represented as mean ± SD. ***p < 0.001; **p < 0.01; ns, not significant.
See also Figure S1.thesemice is characterized by the presence of densely packedB
cell follicles containing a network of CD21/35+ FDCs surrounded
by T cells adjacent to a bronchus (Figures 3B–3D, bottom).
Importantly, spontaneous BALT is largely absent in the lungs of
DC-CCR7+/+ mice (Figure 3E). Quantitative analysis revealed
similar amounts of spontaneous BALT in Ccr7-deficient and
CCR7stop/stop mice, a slight decrease in number and size in
T-CCR7+/+ mice, and an almost complete lack of spontaneous
BALT in DC-CCR7+/+ mice (Figures 3F and 3G). Together, these
data suggest that impaired egress of DCs from the lung causes
formation of spontaneous BALT in Ccr7/ mice.
CCR7-Deficiency Does Not Interfere with the
Development of MVA-Induced BALT
Because BALT develops spontaneously in Ccr7-deficient mice,
and immune cells such as lymphocytes and DCs can home to
BALT independently of CCR7, we hypothesized that MVA-
induced BALT formation is not impaired in the absence of
CCR7. To test this, we treated WT and Ccr7-deficient micewith a single intranasal dose of MVA. 12 days after application,
we observed BALT formation in WT, in Ccr7-deficient mice,
and in selective Ccr7-proficient mice (Figures 4A–4D). While
the number per section as well as the individual size of BALT
was similar in WT, T-CCR7+/+, and DC-CCR7+/+ mice, both
parameters were increased in Ccr7-deficient mice (Figures 4E
and 4F). Together, these data indicate that Ccr7-deficiency
does not interfere with MVA-induced BALT formation but leads
to an increase in size and number of BALT structures.
Intact Trafficking of DCs Prevents the Formation of
Spontaneous BALT in plt/plt Mice
The CCR7-CCR7L axis is also affected in plt/pltmice, a sponta-
neously occurring mutant in which the Ccl19 and the Ccl21-
serine gene have been lost while the Ccl21-leucine gene is still
present. Among other defects, plt/plt mice show impaired hom-
ing of T cells and DCs to secondary lymphoid organs and abnor-
malities in the localization of DCs within lymphoid organs (Gunn
et al., 1999; Nakano et al., 1997, 1998). Interestingly, in contrastCell Reports 23, 783–795, April 17, 2018 785
Figure 2. The Role of Chemokines during
Lymphocyte Homing to BALT
(A, C, G, and I) Immunofluorescence microscopy
of lungs from 8- to 12-week-old C57BL/6 WTmice
either 30 min or 24 hr after simultaneous i.v.
transfer of either WT and Ccr7–/– T cells (A), WT
and Cxcr5–/– B cells (C), pertussis toxin (ptx) and
control-treated lymphocytes (G), or WT and
Cxcr5–/–Ccr7–/– lymphocytes (I) into BALT-bearing
WT mice. Transferred cells were fluorescently
labeled. Frozen lung sections were stained with
the antibodies indicated.
(B, D, H, and J) Quantification of BALT-homed
T cells (B), B cells (D), or lymphocytes (H and J)
30 min or 24 hr after i.v. transfer. Data are derived
from at least two independent experiments and
are represented as mean ± SD. ***p < 0.001;
*p < 0.05; ns, not significant.
(E) Immunofluorescence microscopy of BALT in
the lungs of 8- to 12-week-old C57BL/6 WT mice
either 30 min or 24 hr after simultaneous i.t.
transfer of WT and Ccr7–/– DCs into BALT-bearing
WT mice. Frozen lung sections were stained with
the antibodies indicated.
(F) Quantification of BALT-homed WT and Ccr7–/–
DCs 30 min or 24 hr after i.t. transfer. Data are
derived from at least two independent experi-
ments with 4–7 mice and are represented as
mean ± SD; ns = not significant. Bars, 100 mm.
Dashed lines define area of BALT.to Ccr7-deficient mice, we not only failed to detect spontaneous
BALT but also any lymphoid infiltrations in the lungs of plt/plt
mice (Figure 5A). An explanation for this unexpected finding
could be that one isoform of CCL21 (CCL21-leucine) is still ex-
pressed on lymphatic vessels in non-lymphoid organs of plt/plt
mice (Lo et al., 2003; Luther et al., 2000; Nakano and Gunn,
2001; Vassileva et al., 1999). Indeed, as described before (Jurisic
et al., 2010; Kretschmer et al., 2013), we also observed CCL21
expression on CD90+ lymphatic vessels in the lungs of naive
plt/plt mice (Figure 5B).
To analyze the migration defect of DCs in plt/plt mice, we i.t.
transferred fluorescently labeled WT and Ccr7-deficient DCs
into naive WT or plt/plt recipient mice. 24 hr after the transfer,
we quantified transferred DCs in the lung as well as in the
draining bronchial and the non-draining inguinal LN. As
described earlier (Hintzen et al., 2006), in both WT and plt/plt786 Cell Reports 23, 783–795, April 17, 2018recipients significantly more Ccr7-defi-
cient than WT DCs could be isolated
from the lung (Figures 5C and 5D).
When directly comparing the retention
of WT DCs transferred in either WT or
plt/plt recipients, we observed a slightly
but not significantly higher number of
DCs retained in the lungs of plt/plt
mice (Figure 5E). Furthermore, while
Ccr7-deficient DCs were completely
excluded from the draining bronchial
LN, WT DCs homed to this organ in
WT and to a lower degree in plt/plt recip-ients (Figure 5F). Neither WT nor in plt/plt recipients harbored
any i.t. transferred DCs in non-draining inguinal LNs
(Figure 5G).
Taken together, these data show that Ccr7-deficient DCs
completely fail to egress from the lung while lung DCs of plt/plt
mice only show a minor migratory defect to the lung draining
LN most likely due to expression of CCL21-leucine. Although
plt/plt mice never developed BALT, further histological analysis
revealed that the salivary and lacrimal glands of these mice
harbored considerable numbers of ectopic lymphoid structures.
However, other organs that show tertiary lymphoid follicles in
Ccr7-deficient mice, such as stomach and pancreas, were less
severely or not at all affected in plt/plt mice (Figure S2). These
findings might indicate a differential role of CCL21-leucine in
DC migration and/or ectopic lymphoid organ formation across
different organs.
Figure 3. CCR7-Dependent Migratory Defects of DCs in the Lung Result in Spontaneous BALT Formation
(A–E) Immunofluorescence panoramic microscopy of naive lungs and detailed microscopy of spontaneous BALT of 8- to 12-week-old C57BL/6 WT (A), Ccr7–/–
(B), CCR7stop/stop (C), T-CCR7+/+ (D), or DC-CCR7+/+ (E) mice. Frozen lung sections were stained with the antibodies indicated. Arrowheads refer to individual
spontaneous BALT. Bars, 100 mm.
(F and G) Number of spontaneous BALT per section and individual size of spontaneous BALT in WT, Ccr7–/–, CCR7stop/stop, T-CCR7+/+, and DC-CCR7+/+ mice.
Data are derived from at least two independent experiments with 3–7 mice and are represented as mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001.
See also Figure S2.MVA-Induced BALT Is Massively Enhanced in plt/plt
Mice
To further address whether lack of CCL21-serine and CCL19
affects virus-induced BALT formation, we analyzed the lungs
of plt/pltmice 12 days after intranasal MVA application. Surpris-
ingly, we observed massive formation of induced BALT in those
mice compared to WT (Figures 6A and 6B). Whereas in plt/plt
mice almost three times more BALT was induced than in
WT mice (plt/plt: 67.1 ± 19.8; WT: 25.0 ± 7.2; mean and SD),
the individual BALT size was only slightly enhanced (Figures
6D and 6E).
We first speculated that this enormous BALT formation in
plt/pltmicemight result from a defect in egress of infiltrating lym-phocytes because it had been suggested that CCR7 is involved
in the egress of lymphocyte subsets from non-lymphoid tissue
including the lung (Bromley et al., 2005; Debes et al., 2005).
Given that CCL21-leucine is still expressed in the lung of plt/plt
mice, we focused on the role of CCL19 in lymphocyte egress,
the second ligand for CCR7 that is missing in plt/plt mice. Inter-
estingly, we did not observe spontaneous BALT in CCL19-defi-
cient mice (data not shown), and intranasal administration of
MVA to those mice induced a similar number and size of BALT
as in WT mice (Figures 6C–6E). These findings did not support
our hypothesis for a relevant role of CCL19 in lymphocyte egress
from the lung. Still, we cannot exclude that deficiency of CCL19
can be compensated by any of the two CCL21 isoforms.Cell Reports 23, 783–795, April 17, 2018 787
Figure 4. The Absence of CCR7 Does Not Interfere with the Development of MVA-Induced BALT
(A–D) Immunofluorescence panoramicmicroscopy ofMVA-treated lungs and detailedmicroscopy ofMVA-induced BALT of 8- to 12-week-oldWT (A),Ccr7–/– (B),
T-CCR7+/+ (C), or DC-CCR7+/+ (D) mice 12 days after i.n. administration of MVA. Frozen lung sections were stained with the antibodies indicated. Arrowheads
refer to individual MVA-induced BALT. Bars, 100 mm.
(E and F) Number and individual size of MVA-induced BALT per section in WT, Ccr7–/–, T-CCR7+/+, and DC-CCR7+/+ mice. Data are derived from at least two
independent experiments with 4–16 mice and are represented as mean ± SD. *p < 0.05; ***p < 0.001.To address this, we intratracheally transferred fluorescently
labeled WT and, as control, Ccr7-deficient lymphocytes into
either naive WT or plt/pltmice. 24 hr after the transfer, we quan-
tified the number of lymphocytes being retained in the lung. In
WT recipients, we observed significantly higher numbers of
retained Ccr7-deficient lymphocytes compared to their WT
counterparts (Figure 6F), consistent with previous data indi-
cating that CCR7 is involved in the egress of lymphocyte subsets
from the lung (Bromley et al., 2005; Debes et al., 2005). In
contrast, in plt/plt recipients, we failed to detect any difference
in the number of adoptively transferred WT or Ccr7-deficient
lymphocytes remaining in the lung (Figure 6G) indicating that
WT lymphocytes are equally impaired in leaving the lung as
Ccr7-deficient cells. Direct comparison of transferred WT lym-
phocytes in either WT or plt/plt recipients revealed a significantly788 Cell Reports 23, 783–795, April 17, 2018increased number of lymphocytes being retained in lungs of
plt/plt mice (Figure 6H). These data demonstrate that CCL21-
serine and/or CCL19 are important for maintaining egress from
the lung, with CCL21-leucine not being sufficient.
plt/plt Mice Are More Susceptible to MVA Infection and
Show a Rapid and Enhanced Formation of BALT
Considering the regular MVA-induced BALT formation in Ccr7-
deficient mice, the observed egress deficiency of lymphocytes
from lungs of plt/plt mice cannot alone explain the massive
induction of BALT upon MVA infection in these mice. We there-
fore performed a detailed comparative kinetic in BALT formation
in WT and plt/plt mice using immunofluorescence microscopy.
Interestingly, we observed a massive perivascular and peribron-
chiolar infiltration of T cells in plt/pltmice at day 3 after intranasal
Figure 5. Intact Trafficking of DCs Prevents the Formation of Spontaneous BALT in plt/plt Mice
(A and B) Immunofluorescence panoramic (A) and detailed (B) microscopy of naive lungs from 8- to 12-week-old plt/pltmice. Frozen lung sections were stained
with the antibodies indicated.
(C and D) Paired analysis of simultaneously transferred WT and Ccr7–/– DCs into untreated WT (C) or plt/plt (D) recipient mice 24 hr after i.t. transfer. Data are
derived from two independent experiments with 5 mice and are represented as mean ± SD. **p < 0.01.
(E) Quantification of transferred WT DCs into untreated WT or plt/plt recipient 24 hr after i.t. transfer. Data are derived from two independent experiments with
5 mice; mean and SD. ns, not significant.
(F and G) Quantification of WT andCcr7–/– DCs either detected in bronchial LN (broLN) (F) or inguinal LN (ingLN) (G) 24 hr after simultaneous i.t. transfer into either
WT or plt/plt recipient mice. Data are derived from two independent experiments with 4–5 mice per group and are represented as mean ± SD. ***p < 0.001.
See also Figure S2.MVA administration (Figure 7A). At day 6 after infection, B cell
follicles have already been formed in plt/plt mice, whereas in
WT mice, T cells have primarily been recruited to the lung, but
these were still scattered diffusely around vessels and bronchi-
oles (Figure 7B). In plt/plt mice, organized BALT characterized
by separated T and B cell zones containing FDCs had been
formed by day 8 (Figure 7C, not depicted) while at this time point,
B cells just started to segregate toward the center of BALT inWT
mice (Figure 7C). At day 12 after infection, large amounts of BALT
had formed in plt/plt mice and displayed pronounced B cell
follicles attended by T cells (Figure 7D). At the same time point,
mature BALT defined by densely packed B cell follicles contain-
ing a network of FDCs (not depicted) surrounded by T cells was
most abundantly present in WT mice (Figure 7D). Quantitativeanalysis revealed that at any time point after MVA administration
higher numbers of lymphoid infiltrates were present in plt/plt than
in WT mice (Figure 7E, left). Furthermore, regardless of their
organization or cellular composition, individual lymphoid infil-
trates were larger in plt/plt mice (Figure 7E, middle), and as a
consequence, the cumulative lymphoid size was higher in plt/plt
mice at any time point analyzed (Figure 7E, right). Quantifying
only mature BALT at day 12 after infection revealed three times
more BALT in plt/plt compared to WT mice (Figure 7F). The
high numbers of infiltrating T cells observed in plt/plt mice as
early as at 3 days post infection (p.i.) raised the question whether
plt/plt mice are more susceptible to intranasal MVA infection
than WT mice. To answer this question we took advantage of a
MVA reporter virus to visualize all infected cells (Kremer et al.,Cell Reports 23, 783–795, April 17, 2018 789
Figure 6. Massive Induction of MVA-Induced BALT in plt/plt Mice
(A–C) Immunofluorescence panoramicmicroscopy ofMVA-treated lungs and detailedmicroscopy ofMVA-induced BALT of 12- to 16-week-oldWT (A), plt/plt (B),
and Ccl19–/– (C) mice 12 days after i.n. administration of MVA. Frozen lung sections were stained with the antibodies indicated. Arrowheads refer to individual
MVA-induced BALT. Bars, 100 mm.
(D and E) Number and individual size of MVA-induced BALT per section in WT, plt/plt, and Ccl19–/– mice. Data are derived from at least two independent ex-
periments with 7–11 mice and are represented as mean ± SD. ***p < 0.001.
(F and G) Paired analysis of simultaneously transferred WT and Ccr7–/– lymphocytes into untreated WT (F) or plt/plt (G) recipient mice 24 hr after i.t. transfer. Data
are derived from two independent experiments with 5 mice and are represented as mean ± SD. **p < 0.01.
(H) Quantification of transferredWT lymphocytes into untreatedWT or plt/plt recipient 24 hr after i.t. transfer. Data are derived from two independent experiments
with 5 mice and are represented as mean ± SD. **p < 0.01.2012). Intranasal administration of MVA-mCherry identified four
times more infected cells in lungs of plt/plt than in WT at d1 p.i.
(Figure 7G). Further analysis of the cell types being infected
revealed that alveolar macrophages, endothelial cells, as well
as ‘‘other’’ not further-specified cells were equally more suscep-
tible toward MVA infection in plt/plt relative to WT mice (Fig-
ure 7H). This increase in MVA susceptibility was paralleled by
augmented immune cell recruitment to the lung of plt/plt mice
as early as at day 1 p.i. (Figure 7I). Day 1 infiltrates in both WT
and plt/plt mice primarily comprise of neutrophils, B cells, and
T cells (Figures 7I–7K) with the latter being significantly enhanced
in plt/plt mice.
DISCUSSION
The present study identified amultifaceted role of the chemokine
receptor CCR7 and its ligands, CCL19 and CCL21 in the induc-
tion and maintenance of BALT. We show that lack of CCR7 on
DCs but not T cells was responsible for spontaneous BALT for-
mation in Ccr7/ mice, and the pronounced accumulation of
lymphocytes in BALT and lungs of plt/plt mice was caused by
impaired lymphocyte egress most likely due to lack of CCL21-
serine in these animals. Furthermore, this study identified 2 path-790 Cell Reports 23, 783–795, April 17, 2018ways that facilitate entry into BALT. One is directly from blood via
high endothelial venules (HEV) and depends on L-selectin as well
as CCR7/CCR7-ligands, whereas the second pathway is via
the lung parenchyma and is independent of both signaling
pathways.
Ectopic lymphoid tissues not only generate protective immune
responses but are also suspected to the exacerbation of patho-
logical immune-mediated processes. Therefore, a better under-
standing of the processes that regulate the continuous exchange
of immune cells in tertiary lymphoid organs is needed. It is widely
accepted for LNs that blood lymphocytes enter LNs via HEVs by
a highly controlled multi-step adhesion cascade in which integ-
rins as well as chemokines and their receptors orchestrate
immune cell trafficking (Fo¨rster et al., 2008). Concerning the pre-
cise composition of homing molecules involved, this cascade
shows some degree of organ specificity, thereby enabling
certain subsets of leukocytes to migrate preferentially into their
specific target tissue (Kunkel and Butcher, 2002). Similar to
LNs, BALT is equipped with T cell areas harboring HEVs (Sminia
et al., 1989) as well as postcapillary venules and lymphatic ves-
sels. Although BALT clearly plays a role in pulmonary immunity,
and lymphocytes are thought to home to BALT via HEVs, little is
known about the multistep cascade that controls the migration
(legend on next page)
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of lymphocytes to BALT. In this study, we now formally show that
intravenously transferred lymphocytes home to MVA-induced
BALT primarily via HEVs. We show that BALT homing via HEVs
depends on L-selectin as well as on CCR7, and this route allows
instantaneous entry of blood cells. However, our study also
revealed a second port of entry into BALT that is independent
of CCR7 and L-selectin and allows delayed homing of blood-
derived immune cells via the lung parenchyma into BALT. Mole-
cules involved in that homing route have not been addressed in
this study. Furthermore, it remains unclear to what extent lym-
phocytes that have been primed in the lung-draining LN after
MVA infection contributes to BALT formation. It has been shown
before that activated lymphocytes can be efficiently recruited
into inflamed tissue independent of CCR7 (Cupovic et al.,
2016), but further studies are needed to clarify whether this is
also the case for activated lymphocytes in MVA-induced BALT.
We reported earlier that Ccr7-deficient mice spontaneously
develop BALT (Kocks et al., 2007) and now provide genetic evi-
dence that deficiency of CCR7 on DCs impairs their sponta-
neous egress from the lung that ultimately leads to the formation
of BALT in the lung. The accumulation of DCs in non-lymphoid
areas has been correlated earlier with the formation of ectopic
lymphoid tissue (Ho¨pken et al., 2007), and the repetitive intratra-
cheal transfers of bone-marrow-derived DCs to otherwise
untreated mice resulted in BALT formation in WT mice (Geurts-
vanKessel et al., 2009). These authors suggest a model by which
DCs provide a continuous source of LTb that recruits and retains
B cells inside BALT in a CXCL13-dependent manner. Still, it
remained unclear what kind of initial trigger leads to the initiation
of BALT formation.
Here, we show that impaired steady-state egress of DCs from
the lung is a sufficient trigger for BALT induction.Ccr7-knockout-
knockin mice, in which CCR7 expression is restricted to DCs and
allows them to regain their migratory capability, show efficient
DC-homing to the draining LN, but not any spontaneous BALT
formation. Along the same line, lungs of naive plt/plt mice that
lack lymphoid CCL21-serine and CCL19 but express CCL21-
leucine also do not develop spontaneous BALT. Although,
CCR7-mediated DC egress from the lung is less efficient when
only CCL21-leucine is present. Data of the present study pro-
vides circumstantial evidence that the CCR7-CCL21-leucineFigure 7. Early Enhanced Lymphoid Infiltrations upon MVA Infection in
(A–D) Immunofluorescence microscopy of lungs from 8- to 12-week-old plt/plt (to
i.n. MVA treatment. Frozen lung sections were stained with the antibodies indica
(E) Number, individual, and cumulative size of lymphoid aggregates per lung sec
treatment. Data are derived from at least two independent experiments with 5–1
(F) Number of BALT per lung section in WT and plt/plt at day 12 after MVA treatm
(G) Immunofluorescence microscopy (left) and quantification of infected cells in
mCherry. Frozen lung sections were stained with DAPI. Data are derived from tw
(H) Relative frequency of different cell types infected by MVA-mCherry 1 day aft
pendent experiments with 4–5 mice. aMQ, alveolar macrophage.
(I) Immunofluorescence panoramic (left) and detailed microscopy (right) of lungs
Frozen lung sections were stained with the antibodies indicated.
(J) Flow cytometry of single-cell suspensions of lungs from WT (left) and plt/plt (r
Gate on all alive CD45+ cells.
(K) Absolute number of neutrophils, CD11b+ cells, T cells, and B cells in lung
representative for two independent experiments with 4–5 mice analyzed. Data ar
Arrowheads indicate unspecific staining of vessels and bronchi that are also pre
792 Cell Reports 23, 783–795, April 17, 2018axis appears to be sufficient in preventing spontaneous tertiary
lymphoid tissue formation in the lung. However, it is currently
unclear whether this mechanism also prevents the spontaneous
formation of ectopic lymphoid tissue in other organs. The obser-
vation that some but not all organs know to be targets of autoim-
mune diseases can spontaneously develop ectopic lymphoid
follicles in plt/plt mice actually indicates a differential role of
this chemokine across tissues in tertiary lymphoid tissue
formation.
Still, plt/pltmice show a strong overreaction in BALT formation
once this is induced by a virus such as MVA. We observed both
increased BALT structures as well as larger individual BALT
areas in plt/plt mice compared to WT mice. Enhanced airway
inflammation has been reported in plt/pltmice before, as charac-
terized by increased influx of eosinophils, higher levels of IL-4
and IL-13, combined with profound inflammation in peribron-
chiolar and perivascular areas compared to WT mice (Grinnan
et al., 2006; Takamura et al., 2007; Xu et al., 2007; Yamashita
et al., 2006). Moreover, BALT induction by mycobacterial and
influenza infections in plt/plt mice has been reported before
(Kahnert et al., 2007; Rangel-Moreno et al., 2007). However, con-
trary to our findings, those groups did not observe an enhanced
formation or organization of BALT, but instead observed a regu-
lar or even impaired one. The reasons for these different obser-
vations are currently unclear, but it seems possible that this is
due to the different pathogens used in these studies. Indeed,
we have previously shown that different pathogens, such as
MVA and Pseudomonas aeruginosa, both strong BALT inducers,
used very different signaling pathways for induction of tertiary
lymphoid organs (Fleige et al., 2014).
As mentioned above, it has been suggested before that CCR7
is involved in the egress of lymphocytes from non-lymphoid
organs like skin or lung (Bromley et al., 2005; Debes et al.,
2005). Interestingly, Grinnan et al. (2006) observed impaired
exit of CD4+ and CD8+ T cells, but no egress defect of DC sub-
sets, from the lungs in plt/plt mice. Along this line, we observed
that DCs only showminor egress defects in plt/pltmice, whereas
a large number of intratracheally transferred lymphocytes was
retained in plt/plt lungs. It could be that mechanisms in addition
to CCR7 direct lymphocytes from the lung to the draining LNs or
that lymphocytes, but not DCs, rely on the presence of boththe Lungs of plt/plt Mice
p) andWT (bottom) mice 3 days (A), 6 days (B), 8 days (C), and 12 days (D) after
ted.
tion in WT or plt/plt mice 3 days, 6 days, 8 days, and 12 days after i.n. MVA
0 mice.
ent. Data are derived from three independent experiments with 6–10 mice.
the lungs from WT (left) and plt/plt (right) mice 1 day after infection with MVA-
o independent experiments with 4–5 mice.
er i.n. administration of WT and plt/plt mice. Data are derived from two inde-
from WT (top) and plt/plt (bottom) mice 1 day after i.n. administration of MVA.
ight) mice 1 day after i.n. administration of MVA using antibodies as indicated.
s of MVA-infected WT and plt/plt mice 1 day after administration. Data are
e represented as mean ± SD. *p < 0.05; **p < 0.01; ***p < 0.001. Bars, 100 mm.
sent in controls lacking primary antibodies.
isoforms of CCL21 and/or the presence of CCL19 on lymphatic
vessels to efficiently leave the lung. Because the analysis of
Ccl19-deficient mice did not reveal any abnormal retention of
lymphocytes or enhanced levels ofMVA-induced BALT, it seems
that CCL21-serine is the essential factor that drives lymphocyte
egress from lung. Another explanation could be the 1,000-fold
higher sensitivity of DCs toward CCL21 and CCL19 compared
to T cells resulting in more efficient exit from the lung, particularly
if chemokines are limited (Kellermann et al., 1999).
Comparative kinetics in BALT-formation revealed profound
differences between WT and plt/plt mice. It turned out that in
plt/plt mice, both T cells and B cells are recruited much faster
and organized BALT forms as early as at day 6 after MVA appli-
cation. Furthermore, we found massive infiltrations of neutro-
phils in the early phase after infection in plt/plt lungs. The reason
for the exaggerated immune reaction are currently unclear but
are paralleled by our finding that 1 day p.i. plt/plt mice showed
a 4-fold increase of infected cells in the lungs with alveolar mac-
rophages and epithelial cells being equally affected. Because
MVA cannot replicate in mammals, these observations demon-
strate that plt/plt mice are more susceptible to the primary
infection with MVA. This finding helps to explain the high
amount of MVA-induced BALT found in these mice. Although
the underlying molecular mechanism for this effect is unclear,
it is unlikely that the deletion of CCL19 and CCL21-serine in
plt/plt mice is directly responsible for increased susceptibility
to MVA because neither CCL19 nor CCL21 showed any effect
in vitro on MVA infection of alveolar macrophages (H.F., J.R.,
and R.F., unpublished data). Likewise, neither alveolar macro-
phages or epithelial cells, both targets for MVA, express
CCR7 or CCR7 ligands. However, because the plt/plt
mutation originally occurred in an outbred mouse strain, it
cannot be excluded that genetic differences other than the
deletion of the CCL19 and CCL21-serine locus in plt/plt mice
trigger increased susceptibility to MVA infection. Clearly, further
studies are needed to clarify this issue.EXPERIMENTAL PROCEDURES
Mice
Mice were bred at a local animal facility or purchased from Charles River.
Ccr7–/– mice (Fo¨rster et al., 1999), Ccr7 gene-targeted mice (Wendland
et al., 2011), Blr1–/– (Cxcr5-deficient) mice (Fo¨rster et al., 1996), Cxcr5–/–
Ccr7–/– mice (Ohl et al., 2003), plt/plt mice (Nakano et al., 1998), and
Ccl19–/– mice (Link et al., 2007) have been previously described. C57BL/
6-plt/plt were produced by backcrossing of plt/plt mice (B6N:DDD-plt/Nkno
B6.DDD-Ccl21bplt). All animals were maintained under SPF conditions and
used at the age of 8–21 weeks. Both male and female mice were used
throughout experiments in an equal manner. All experiments were performed
in accordance with local animal welfare regulations reviewed by the institu-
tional review board and the Lower Saxony State Office for Consumer Protec-
tion and Food Safety (TVV 12/0826, TVV 17/2568).MVA
Recombinant MVA constructs have been described previously (Halle et al.,
2016). In brief, MVA-mCherry were generated by homologous recombination
using the plasmid vector pIIIdHR-P7.5 according to standard procedures
(Kremer et al., 2012). For intranasal administration, mice were deeply anaes-
thetized with ketamine/xylazine, and 107 IU MVA diluted in 40 mL PBS was
applied to the nostrils.Immunohistology
For immunohistology,micewereperfused,organsembedded inTissue-TekOCT
(Sakura), and frozen on dry ice. Fixed cryosections were rehydrated, blocked,
and stained with different antibody ‘‘cocktails’’ at room temperature for 45 min.
Chemokine staining was performed by using a tyramide signal amplification
(TSA) Cyanine 3 system (PerkinElmer).
Quantification of BALT
The amount of BALT was quantified as described before (Fleige and Fo¨rster,
2017). In brief, panoramic images of whole central sections of four different
planes (close to main bronchi and vessels) per lung/mice were analyzed. Indi-
vidual BALT structures were counted, measured, and the cumulative lymphoid
size was calculated as the sum of all individual lymphoid structures present on
one central lung section (polygon tool, cell^ P/cellSens software, Olympus).
Isolation of Lungs and Flow Cytometry
Lungs from 8- to 14-week-old mice were perfused and digested for 60 min at
37C. Red blood cells were lysed and single cell suspensions were blocked
and incubated for 20min on ice with different ‘‘cocktails’’ of antibodies. Finally,
cells were washed and re-suspended with DAPI.
Adoptive Transfer of Lymphocytes
Either unsorted or magnetic-activated cell sorting (MACS) lymphocytes were
isolated from spleen and LNs of C57BL/6 WT, Ccr7–/–, Cxcr5–/–, or
Cxcr5–/–Ccr7–/– mice and 1–5 3 107 fluorescently labeled cells were trans-
ferred i.v. into naive or BALT-bearing WT, Ccr7/, or plt/plt recipients.
30 min, 4 hr, or 24 hr after the transfer, recipients were sacrificed, and the
lung and LNs were harvested.
Blockade of L-selectin (CD62L) by In Vivo Administration of
Anti-L-selectin Monoclonal Antibody
To block lymphocyte homing via HEVs, 250 mg anti-L-selectin monoclonal
antibody (mAb) (Mel-14) or 250 mg isotype control (1H4) was given intraperito-
neally (i.p.) into BALT-bearing mice 30 min before i.v. transfer of fluorescently
labeled lymphocytes.
Blockade of Gai-Coupled Receptor Signaling by Incubation of
Lymphocytes with Pertussis-Toxin
WT lymphocytes were incubated with 100 ng pertussis-toxin (ptx) or PBS in
RPMI 1640 supplemented with 5% FCS and 10 mM HEPES for 4 hr at 37C.
Generation of Bone-Marrow-Derived DCs
Bone-marrow-derived DCswere generated from bonemarrow of C57BL/6WT
or Ccr7–/– mice by in vitro culture (Ohl et al., 2004).
Intratracheal Instillation
For intratracheal (i.t.) transfer into naive or BALT-bearing WT or plt/plt recipi-
ents, mice were anesthetized and a blunt cannula (0.7 3 19 mm, B. Braun)
filled with 1–2 3 106 fluorescently labeled DCs or lymphocytes was instilled
through the larynx into the trachea under visual control.
Statistical Analysis
Statistical analysis was performed with Prism 4 (Graph-Pad Software). When
comparing two groups, significant values were determined using unpaired
two-tailed t test. To compare multiple groups, one-way ANOVA was used.
All error bars shown represent mean and SD. Statistical differences for the
mean values are as follows: *p < 0.05; **p < 0.01; ***p < 0.001. All experiments
shown were performed at least twice unless otherwise specified.
Detailed experimental procedures are included in the Supplemental Exper-
imental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and two figures and can be found with this article online at https://doi.org/
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